Company Filing History:
Years Active: 2020-2024
Title: Innovations of Anne Schaap Nutt
Introduction
Anne Schaap Nutt is a prominent inventor based in Austin, TX (US). She has made significant contributions to the field of virology, particularly in the development of recombinant paramyxoviruses. With a total of 3 patents, her work focuses on creating innovative solutions for vaccine formulations.
Latest Patents
Her latest patents include the "Recombinant human parainfluenza virus type 1 expressing a chimeric RSV/HPIV1 F protein and uses thereof." This patent describes recombinant paramyxoviruses that include a viral genome encoding a heterologous gene. In various embodiments, the recombinant paramyxovirus is a recombinant parainfluenza virus, such as a recombinant PIV3. This includes a viral genome encoding a heterologous respiratory syncytial virus F ectodomain linked to the transmembrane domain and the cytoplasmic tail of the F protein from the PIV3. Additionally, nucleic acid molecules that include the genome of these recombinant paramyxoviruses are provided. The recombinant viruses may be used advantageously in vaccine formulations, particularly for vaccines against parainfluenza virus and respiratory syncytial virus.
Another significant patent is the "Recombinant human/bovine parainfluenza virus 1 (HPIV1) expressing a chimeric RSV/HPIV1 F protein and uses thereof." Similar to her previous work, this patent also focuses on recombinant paramyxoviruses that include a viral genome encoding a heterologous gene. The potential applications of these recombinant viruses in vaccine development highlight the importance of her research.
Career Highlights
Anne Schaap Nutt is affiliated with the National Institutes of Health, a component of the US Department of Health & Human Services. Her work at this esteemed institution allows her to collaborate with leading experts in the field and contribute to groundbreaking research.
Collaborations
Some of her notable coworkers include Peter L. Collins and Bo Liang. Their collaborative efforts have further advanced the research and development of innovative vaccine solutions.
Conclusion
Anne Schaap Nutt's contributions to the field of virology through her patents and research at the National Institutes of Health underscore her role as a leading inventor. Her work has the potential to significantly impact vaccine development and public health.